Datacorp is collaborating with Kaiser Permanente Southern California’s Department of Research and Evaluation and Dr. Andrew Weinstein (board-certified allergist and clinical immunologist with expertise in asthma adherence and president of Asthma Management Systems) on a new National Institutes of Health (NIH)-sponsored research study designed to develop a questionnaire to identify asthma patients at risk of poor treatment adherence.
The study will administer a survey to a random sample of adults with asthma who are members of Kaiser Permanente Southern California. It will prospectively monitor prescription refills for those who complete the questionnaire over a six-month period.
Datacorp Principal Investigator, Dr. Diane Turner-Bowker notes, “We are thrilled to work with Kaiser Permanente Southern California’s Department of Research and Evaluation and Dr. Weinstein on this important project, and hope that the resulting survey will make a positive difference in asthma care by offering a valid tool that providers can use to identify those at highest risk for poor treatment adherence. Ultimately, tools like this can inform targeted interventions to help patients better control their asthma.”